A phase 3 trial of Tocagen’s therapy for high-grade glioma (HGG) – a form of brain cancer – failed to show an improvement in overall survival, sending the biotech’s shares into freefall. The Toca 5 ...
Mike Scanlin is the CEO of Born To Sell. He has 37 years of experience trading covered calls and 10 years in venture capital. Gordon Scott has been an active investor and technical analyst or 20+ ...
From lens focal lengths and fill-flash to portraits, macro or stunning landscapes there are techniques for everyone. Learn how to use metering, considering composition and shoot everything from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results